Published in Gene Ther on November 22, 2007
MAP kinase and pain. Brain Res Rev (2008) 3.75
Glia and pain: is chronic pain a gliopathy? Pain (2013) 2.21
Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci (2011) 1.58
TNF-α contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain (2010) 1.31
Progress in gene therapy for neurological disorders. Nat Rev Neurol (2013) 1.22
Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther (2008) 1.17
IL-10 promotes neuronal survival following spinal cord injury. Exp Neurol (2009) 1.16
Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain (2011) 1.15
Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration. J Biol Chem (2009) 1.00
HSV Recombinant Vectors for Gene Therapy. Open Virol J (2010) 0.99
A novel cell-cell signaling by microglial transmembrane TNFα with implications for neuropathic pain. Pain (2010) 0.97
A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther (2009) 0.95
Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain. Gene Ther (2009) 0.93
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha. Neurosci Lett (2008) 0.93
Gene therapy for the treatment of chronic peripheral nervous system pain. Neurobiol Dis (2012) 0.91
Analgesic effect of acupuncture is mediated via inhibition of JNK activation in astrocytes after spinal cord injury. PLoS One (2013) 0.88
Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation (2012) 0.88
Herpes simplex virus vector-mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury. Neurorehabil Neural Repair (2012) 0.87
A clinical trial of gene therapy for chronic pain. Pain Med (2009) 0.86
Long-term control of neuropathic pain in a non-viral gene therapy paradigm. Gene Ther (2009) 0.85
Demethylating drugs as novel analgesics for cancer pain. Clin Cancer Res (2014) 0.84
Regular physical activity prevents chronic pain by altering resident muscle macrophage phenotype and increasing interleukin-10 in mice. Pain (2016) 0.83
Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Ther (2011) 0.83
TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats. Brain Behav Immun (2011) 0.80
Spinal release of tumour necrosis factor activates c-Jun N-terminal kinase and mediates inflammation-induced hypersensitivity. Eur J Pain (2014) 0.80
Current gene therapy using viral vectors for chronic pain. Mol Pain (2015) 0.79
Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats. Anesth Analg (2014) 0.78
IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats. Mol Pain (2014) 0.78
Herpes simplex virus-based nerve targeting gene therapy in pain management. J Pain Res (2014) 0.76
High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs. Gene Ther (2014) 0.76
Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy. Mol Ther Methods Clin Dev (2017) 0.75
Rgulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy. Mol Ther Methods Clin Dev (2017) 0.75
The formalin test: an evaluation of the method. Pain (1992) 7.29
Interleukin-10 and related cytokines and receptors. Annu Rev Immunol (2004) 5.41
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature (1994) 3.15
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev (2002) 2.75
Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol (1997) 2.59
Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem (2003) 2.42
Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist (2004) 2.40
Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience (1997) 2.00
Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J (2001) 1.93
Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain (1997) 1.90
Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol (2003) 1.84
Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain (2000) 1.83
Glial activation and pathological pain. Neurochem Int (2004) 1.80
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport (1996) 1.67
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther (2004) 1.56
Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia (2001) 1.51
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol (2005) 1.47
Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol (2006) 1.43
Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med (2002) 1.42
Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain (2000) 1.34
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain (2006) 1.32
Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther (2003) 1.30
Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol (2001) 1.29
Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat. Neurosci Lett (2003) 1.27
Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J Peripher Nerv Syst (2000) 1.24
Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain (2003) 1.15
The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes. J Immunol (1997) 1.13
Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm (1996) 1.02
Epidural application of nucleus pulposus enhances nociresponses of rat dorsal horn neurons. Spine (Phila Pa 1976) (2002) 0.98
Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome. Am J Respir Cell Mol Biol (2000) 0.89
Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons. Spine (Phila Pa 1976) (2002) 0.82
The complete genome of the crenarchaeon Sulfolobus solfataricus P2. Proc Natl Acad Sci U S A (2001) 7.00
Organization of 'nanocrystal molecules' using DNA. Nature (1996) 6.45
Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor. J Am Chem Soc (2001) 3.74
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem (1994) 3.14
Species and type phages of lactococcal bacteriophages. Intervirology (1991) 2.55
Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42
Genome comparison of Lactococcus strains by pulsed-field gel electrophoresis. FEMS Microbiol Lett (1989) 2.36
Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res (1998) 2.35
Photochemical instability of CdSe nanocrystals coated by hydrophilic thiols. J Am Chem Soc (2001) 2.35
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (1979) 2.22
Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
GeneKeyDB: a lightweight, gene-centric, relational database to support data mining environments. BMC Bioinformatics (2005) 1.83
Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem (1996) 1.80
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem (1980) 1.73
Innovative materials processing strategies: a biomimetic approach. Science (1992) 1.72
Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62
Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia (2002) 1.55
Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat (2011) 1.53
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol (1994) 1.45
Physical and genetic map of the chromosome of Lactococcus lactis subsp. lactis IL1403. J Bacteriol (1992) 1.43
An X Window system for statlab results reporting. Proc Annu Symp Comput Appl Med Care (1993) 1.43
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther (2001) 1.41
Smoking and the development of Warthin's tumour of the parotid gland. Br J Oral Maxillofac Surg (1998) 1.41
Some thoughts on the nature of ectopic parathyroid hormones. Am J Med (1971) 1.39
NMR study of the cold, heat, and pressure unfolding of ribonuclease A. Biochemistry (1995) 1.38
Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther (2007) 1.37
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther (1998) 1.36
New tools for the physical and genetic mapping of Lactococcus strains. Gene (1992) 1.31
Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol (1994) 1.30
Effects of amino acid substitutions on the pressure denaturation of staphylococcal nuclease as monitored by fluorescence and nuclear magnetic resonance spectroscopy. Biochemistry (1993) 1.27
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate. J Biol Chem (1999) 1.26
Taxonomic differentiation of 101 lactococcal bacteriophages and characterization of bacteriophages with unusually large genomes. Appl Environ Microbiol (1990) 1.24
Biomineralization and eggshells: cell-mediated acellular compartments of mineralized extracellular matrix. Int Rev Cytol (1993) 1.22
Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol (1995) 1.22
Gene capture in archaeal chromosomes. Nature (2001) 1.20
Homomeric and native alpha 7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett (1993) 1.20
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol (2000) 1.20
Regulation of acetylcholine release from neuroblastoma x glioma hybrid cells. Proc Natl Acad Sci U S A (1978) 1.19
NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol Res (2006) 1.17
Life events and anxiety in Chinese medical students. Soc Psychiatry Psychiatr Epidemiol (1997) 1.16
Molecular characterization and comparison of 38 virulent and temperate bacteriophages of Streptococcus lactis. J Gen Microbiol (1987) 1.15
Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A (1996) 1.12
Neuronal nicotinic receptor subtypes. Ann N Y Acad Sci (1995) 1.11
In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther (1992) 1.11
Serum cholesterol and primary brain tumours: a case-control study. Int J Epidemiol (1989) 1.11
Vitamin D target proteins: function and regulation. J Cell Biochem (2003) 1.10
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther (1998) 1.08
Differential gene-expression analysis defines a molecular pattern related to olive pollen allergy. J Biol Regul Homeost Agents (2013) 1.07
Multiple primary tumours of the parotid gland. Int J Oral Maxillofac Surg (2004) 1.07
Activation of a rice endogenous retrotransposon Tos17 in tissue culture is accompanied by cytosine demethylation and causes heritable alteration in methylation pattern of flanking genomic regions. Theor Appl Genet (2004) 1.07
Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther (1997) 1.06
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J Virol (1996) 1.06
[Ischemic cardiopathy in primary care. A descriptive study]. Aten Primaria (1990) 1.06
Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes. J Virol (1999) 1.06
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia (2007) 1.05
New form of familial Parkinson-dementia syndrome: clinical and pathologic findings. Neurology (1983) 1.04
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen. Eur Respir J (2003) 1.04
Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia (2006) 1.03
DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits. J Virol (2000) 1.02
The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology (2001) 1.02
Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab (2006) 1.01
Development and use of EST-SSR markers for assessing genetic diversity in the brown planthopper (Nilaparvata lugens Stål). Bull Entomol Res (2011) 1.00
Generation of photorealistic 3D image using optical digitizer. Appl Opt (2012) 1.00
A clinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region. Int J Oral Maxillofac Surg (2008) 1.00
Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test. Pharmacology (2008) 0.99
Grey plumage colouration in the duck is genetically determined by the alleles on two different, interacting loci. Anim Genet (2009) 0.99
Involvement of DNA-dependent protein kinase in UV-induced replication arrest. J Biol Chem (1999) 0.99
Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors. J Virol (1998) 0.99
Factitial oral lesions in an autistic paediatric patient. Int J Paediatr Dent (2003) 0.98
Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Methods Appl (1994) 0.98
Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system. Cell Mol Neurobiol (1991) 0.97
S100 is preferentially distributed in myelin-forming Schwann cells. J Neurocytol (1990) 0.97
Engineering herpes simplex virus vectors for CNS applications. Exp Neurol (1999) 0.97
Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors. Clin Exp Immunol (1998) 0.97
Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes. Mol Pharmacol (1993) 0.96
Isolation of specialized transducing bacteriophages carrying the structural genes of the hexuronate system in Escherichia coli K-12: exu region. J Bacteriol (1978) 0.96
Molecular taxonomy of Lactobacillus phages. Biochimie (1988) 0.96
Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury. Br J Pharmacol (2009) 0.96
Interleukin-4 mediates cell growth inhibition through activation of Stat1. J Biol Chem (2000) 0.95
HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J Neurovirol (2001) 0.95
A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther (2009) 0.95
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol (1999) 0.95